Forest C, Doglio A, Ricquier D, Ailhaud G
Exp Cell Res. 1987 Jan;168(1):218-32. doi: 10.1016/0014-4827(87)90430-7.
A clonal cell line has been established from the interscapular brown adipose tissue (BAT) of the C57 BL/6J +/+ mouse. The line, designated BFC-1, is aneuploid and exhibits both morphological and biochemical properties characteristics of mature adipocytes. Adipose conversion begins after confluence and is accompanied by an early emergence of lipoprotein lipase; a later emergence of glycerol-3-phosphate dehydrogenase and acid: CoA ligase; an increase in the average triglyceride content. Adipose conversion, estimated by activities of enzyme markers, is enhanced at any given time by the continuous presence in the culture medium of insulin and triiodothyronine, both within their physiological range of concentrations. In addition to both hormones, chronic exposure of confluent cells to beta-adrenergics brings similar long-term effects on adipose conversion. The uptake of labelled 2-deoxyglucose by differentiated BFC-1 cells is stimulated by insulin; the half-maximum effect is observed at 1 nM insulin. Differentiated BFC-1 cells, in which endogenous triglycerides have been prelabelled on the fatty acid moiety, do respond to beta-adrenergics by releasing radioactive fatty acids. The agonist potency order and the EC50 value for each agonist are BRL 37344 (0.5 nM) greater than isoproterenol (1.5 nM) greater than norepinephrine (3 nM) greater than epinephrine (7 nM) greater than salbutamol (15 nM). The half-maximally and maximally effective concentrations of corticotropin to stimulate lipolysis are found to be 4 and 100 nM, respectively. The lipolytic response to isoproterenol is counteracted by prior addition of insulin or simultaneous addition of propranolol. Parallel studies performed on Ob17 cells, a clonal line established from mouse white adipose tissue (Négrel et al., Proc natl acad sci US 75 (1978) 6054), show that the agonist potency order and the EC50 value for each agonist are BRL 37344 (3 nM) greater than isoproterenol (10 nM) greater than norepinephrine (20 nM) greater than epinephrine (40 nM). Thus both BFC-1 cells and Ob17 cells show an atypical beta-adrenoreceptor similar to that described in rat adipocytes (Arch et al., Nature 309 (1984) 163), but the sensitivity of BFC-1 cells toward beta-agonists is found to be 6-fold higher than that of Ob17 cells. Thus the BFC-1 line represents a useful model for the study of short- and long-term responses to beta-adrenergics.
已从C57 BL/6J +/+小鼠的肩胛间棕色脂肪组织(BAT)中建立了一个克隆细胞系。该细胞系命名为BFC-1,为非整倍体,具有成熟脂肪细胞的形态学和生化特性。汇合后开始脂肪转化,并伴随着脂蛋白脂肪酶的早期出现;随后甘油-3-磷酸脱氢酶和酰基辅酶A连接酶出现;平均甘油三酯含量增加。通过酶标志物活性估计的脂肪转化,在任何给定时间,通过在培养基中持续存在生理浓度范围内的胰岛素和三碘甲状腺原氨酸而增强。除了这两种激素外,汇合细胞长期暴露于β-肾上腺素能药物对脂肪转化也有类似的长期影响。分化的BFC-1细胞对标记的2-脱氧葡萄糖的摄取受胰岛素刺激;在1 nM胰岛素时观察到半数最大效应。分化的BFC-1细胞,其内源性甘油三酯已在脂肪酸部分预先标记,确实会通过释放放射性脂肪酸对β-肾上腺素能药物作出反应。每种激动剂的激动剂效价顺序和EC50值为:BRL 37344(0.5 nM)>异丙肾上腺素(1.5 nM)>去甲肾上腺素(3 nM)>肾上腺素(7 nM)>沙丁胺醇(15 nM)。发现促肾上腺皮质激素刺激脂肪分解的半数最大有效浓度和最大有效浓度分别为4 nM和100 nM。对异丙肾上腺素的脂肪分解反应可通过预先添加胰岛素或同时添加普萘洛尔来抵消。对Ob17细胞(一种从小鼠白色脂肪组织建立的克隆细胞系,Négrel等人,《美国国家科学院院刊》75(1978)6054)进行的平行研究表明,每种激动剂的激动剂效价顺序和EC50值为:BRL 37344(3 nM)>异丙肾上腺素(10 nM)>去甲肾上腺素(20 nM)>肾上腺素(40 nM)。因此,BFC-1细胞和Ob17细胞都显示出与大鼠脂肪细胞中描述的类似的非典型β-肾上腺素能受体(Arch等人,《自然》309(1984)163),但发现BFC-1细胞对β-激动剂的敏感性比Ob17细胞高6倍。因此,BFC-1细胞系是研究对β-肾上腺素能药物短期和长期反应的有用模型。